Clinical Trial Update: Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing safety, tolerability, and efficacy of MBS2320 in patients with rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MBS2320

Snippet

Sponsor: Modern Biosciences Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED